Sharps Compliance (SMED) 10-Q 4 May 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2017	May 02, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	SHARPS COMPLIANCE CORP
Entity Central Index Key	898,770
Current Fiscal Year End Date	--06-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		16,006,157
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2017

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2017	Jun. 30, 2016
CURRENT ASSETS
Cash and cash equivalents	$ 5,692	$ 12,435
Accounts receivable, net of allowance for doubtful accounts of $74 and $63, respectively	5,191	5,814
Inventory, net	4,526	3,919
Prepaid and other current assets	853	695
TOTAL CURRENT ASSETS	16,262	22,863
PROPERTY, PLANT AND EQUIPMENT, net	6,756	5,032
OTHER ASSETS	118	84
GOODWILL	6,724	1,039
INTANGIBLE ASSETS, net of accumulated amortization of $954 and $502, respectively	4,162	1,129
TOTAL ASSETS	34,022	30,147
CURRENT LIABILITIES
Accounts payable	2,469	1,620
Accrued liabilities	1,340	1,534
Current maturities of long-term debt	604	0
Deferred revenue	2,223	2,477
TOTAL CURRENT LIABILITIES	6,636	5,631
LONG-TERM DEFERRED REVENUE, net of current portion	498	483
OTHER LONG-TERM LIABILITIES	166	190
LONG-TERM DEBT, net of current portion	2,121	0
TOTAL LIABILITIES	9,421	6,304
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Common stock, $0.01 par value per share; 20,000,000 shares authorized;16,301,722 and 15,740,458 shares issued, respectively and 16,006,157 and 15,444,843 shares outstanding, respectively	163	158
Treasury stock, at cost, 295,615 shares repurchased	(1,554)	(1,554)
Additional paid-in capital	27,946	25,331
Accumulated deficit	(1,954)	(92)
TOTAL STOCKHOLDERS' EQUITY	24,601	23,843
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 34,022	$ 30,147

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2017	Jun. 30, 2016
CURRENT ASSETS
Accounts receivable, allowance for doubtful accounts	$ 74	$ 63
INTANGIBLE ASSETS, accumulated amortization	$ 954	$ 502
STOCKHOLDERS' EQUITY
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	16,301,722	15,740,458
Common stock, shares outstanding (in shares)	16,006,157	15,444,843
Treasury stock, shares repurchased (in shares)	295,615	295,615

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
REVENUES	$ 8,588	$ 6,652	$ 27,826	$ 24,513
Cost of revenues	6,236	4,959	19,620	16,622
GROSS PROFIT	2,352	1,693	8,206	7,891
Selling, general and administrative	2,790	2,709	9,388	7,890
Depreciation and amortization	200	88	600	210
OPERATING LOSS	(638)	(1,104)	(1,782)	(209)
OTHER INCOME (EXPENSE)
Interest income	4	8	12	26
Interest expense	(34)	0	(92)	0
TOTAL OTHER (EXPENSE) INCOME	(30)	8	(80)	26
LOSS BEFORE INCOME TAXES	(668)	(1,096)	(1,862)	(183)
TOTAL INCOME TAX BENEFIT	0	(54)	0	24
NET LOSS	$ (668)	$ (1,042)	$ (1,862)	$ (207)
NET LOSS PER COMMON SHARE
Basic and Diluted (in dollars per share)	$ (0.04)	$ (0.07)	$ (0.12)	$ (0.01)
WEIGHTED AVERAGE SHARES USED IN COMPUTING NET LOSS PER COMMON SHARE:
Basic and Diluted (in shares)	15,994	15,462	15,930	15,449

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balances at Jun. 30, 2015	$ 156	$ (809)	$ 24,344	$ (105)	$ 23,586
Balances (in shares) at Jun. 30, 2015	15,575,041	(191,250)
Exercise of stock options	$ 1	$ 0	312	0	313
Exercise of stock options (in shares)	112,425	0
Stock-based compensation	$ 0	$ 0	676	0	676
Issuance of restricted stock	$ 1	0	(1)	0	0
Issuance of restricted stock (in shares)	52,992
Shares repurchased	$ 0	$ (745)	0	0	(745)
Shares repurchased (in shares)		(104,365)
Net income (loss)	0	$ 0	0	13	13
Balances at Jun. 30, 2016	$ 158	$ (1,554)	25,331	(92)	$ 23,843
Balances (in shares) at Jun. 30, 2016	15,740,458	(295,615)			15,444,843
Exercise of stock options	$ 0	$ 0	342	0	$ 342
Exercise of stock options (in shares)	95,050	0			95,050
Stock-based compensation	$ 0	$ 0	389	0	$ 389
Issuance of restricted stock	$ 1	0	(1)	0	0
Issuance of restricted stock (in shares)	52,992
Issuance of common stock for acquisition	$ 4	$ 0	1,885	0	$ 1,889
Issuance of common stock for acquisition (in shares)	413,272	0
Shares repurchased (in shares)					0
Net income (loss)	$ 0	$ 0	0	(1,862)	$ (1,862)
Balances at Mar. 31, 2017	$ 163	$ (1,554)	$ 27,946	$ (1,954)	$ 24,601
Balances (in shares) at Mar. 31, 2017	16,301,772	(295,615)			16,006,157

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,862)	$ (207)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	1,100	601
Loss on disposal of property, plant and equipment	10	0
Stock-based compensation expense	389	510
Changes in operating assets and liabilities, net of effects of business acquisitions:
Accounts receivable	1,118	2,764
Inventory	(477)	(1,285)
Prepaid and other assets	(192)	(79)
Accounts payable and accrued liabilities	335	(1,122)
Deferred revenue	(239)	308
NET CASH PROVIDED BY OPERATING ACTIVITIES	182	1,490
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(2,439)	(1,217)
Cash proceeds from sale of property, plant and equipment	23	0
Additions to intangible assets	(128)	0
Payments for business acquisitions, net of cash acquired	(7,261)	(1,552)
NET CASH USED IN INVESTING ACTIVITIES	(9,805)	(2,769)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	342	313
Shares repurchased	0	(745)
Proceeds from long-term debt	5,600	0
Repayments of long-term debt	(3,062)	0
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	2,880	(432)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(6,743)	(1,711)
CASH AND CASH EQUIVALENTS, beginning of period	12,435	15,157
CASH AND CASH EQUIVALENTS, end of period	5,692	13,446
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Income taxes paid	0	143
Interest paid on long-term debt	91	0
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock for acquisition	1,889	0
Unpaid consideration related to acquisitions	52	181
Transfer of equipment to inventory	130	114
Property, plant and equipment financed through accounts payable	$ 66	$ 0

ORGANIZATION AND BACKGROUND

ORGANIZATION AND BACKGROUND	9 Months Ended
	Mar. 31, 2017
ORGANIZATION AND BACKGROUND [Abstract]
ORGANIZATION AND BACKGROUND	NOTE 1 - ORGANIZATION AND BACKGROUND Organization Business ® ® SM ® ® .

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Mar. 31, 2017
BASIS OF PRESENTATION [Abstract]
BASIS OF PRESENTATION	NOTE 2 - BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and with instructions to Form 10-Q and, accordingly, do not include all information and footnotes required under accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, these interim condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of March 31, 2017, the results of its operations for the three and nine months ended March 31, 2017 and 2016, cash flows for the nine months ended March 31, 2017 and 2016 and stockholders’ equity for the nine months ended March 31, 2017. The results of operations for the three and nine months ended March 31, 2017 are not necessarily indicative of the results to be expected for the entire fiscal year ending June 30, 2017. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended June 30, 2016.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Mar. 31, 2017
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES Revenue Recognition The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During the three and nine months ended March 31, 2017, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $0.7 million and $2.5 million, respectively. During the three and nine months ended March 31, 2016, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $0.4 million and $2.7 million, respectively. As of March 31, 2017 and June 30, 2016, $2.6 million and $2.1 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program. Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities. Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale. Business Combinations Income Taxes Accounts Receivable Stock-Based Compensation Fair Value of Financial Instruments Fair Value Measurements · Level 1 – Quoted prices in active markets for identical assets or liabilities. · Level 2 – Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities). · Level 3 – Significant unobservable inputs (including our own assumptions in determining fair value). We use the cost, income or market valuation approaches to estimate the fair value of our assets and liabilities when insufficient market-observable data is available to support our valuation assumptions. The purchase price allocations relating to the acquisitions completed during the nine months ended March 31, 2017 and 2016 utilized level 3 inputs.

RECENTLY ISSUED ACCOUNTING STAN

RECENTLY ISSUED ACCOUNTING STANDARDS	9 Months Ended
	Mar. 31, 2017
RECENTLY ISSUED ACCOUNTING STANDARDS [Abstract]
RECENTLY ISSUED ACCOUNTING STANDARDS	NOTE 4 – RECENTLY ISSUED ACCOUNTING STANDARDS In May 2014, guidance for revenue recognition was issued which supersedes the revenue recognition requirements currently followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. Companies have an option to use either a retrospective approach or cumulative effect adjustment approach to implement the standard. The guidance is effective for annual reporting periods beginning after December 15, 2017 (effective July 1, 2018 for the Company.) The Company is in the initial stages of evaluating the impact that the new accounting guidance will have on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company. In July 2015, guidance for inventory measurement was issued, which supersedes the policy currently followed by the Company. The new guidance requires the Company to measure inventory at the lower of cost and net realizable value. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within that reporting period. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. evaluating the impact of the new guidance on its consolidated financial statements and related disclosures. In March 2016, new guidance for stock-based compensation was issued, which simplifies the accounting for stock-based compensation related to income taxes and balance sheet and cash flow classifications. In addition, an entity can make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within the reporting period. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements.

INCOME TAXES

INCOME TAXES	9 Months Ended
	Mar. 31, 2017
INCOME TAXES [Abstract]
INCOME TAXES	NOTE 5 - INCOME TAXES The establishment of valuation allowances requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. Under generally accepted accounting principles, the valuation allowance has been recorded to reduce the Company’s net deferred tax asset to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes. The Company’s net deferred tax assets have been fully reserved by a tax valuation allowance. No income tax expense was recorded for the nine months ended March 31, 2017 as it was not material due to the valuation allowance and net operating losses. The Company’s effective tax rate for the nine months ended March 31, 2016 was 13.1% reflecting estimated state income taxes. The Company’s tax benefit associated with taxable losses during the nine months ended March 31, 2017 was offset by a deferred tax valuation allowance. The Company’s tax expense associated with taxable income during the nine months ended March 31, 2016 was offset by the utilization of net operating loss carryforwards.

NOTES PAYABLE AND LONG-TERM DEB

NOTES PAYABLE AND LONG-TERM DEBT	9 Months Ended
	Mar. 31, 2017
NOTES PAYABLE AND LONG-TERM DEBT [Abstract]
NOTES PAYABLE AND LONG-TERM DEBT	NOTE 6 - NOTES PAYABLE AND LONG-TERM DEBT On March 29, 2017, the Company entered into to a credit agreement with a commercial bank (“Credit Agreement”). The Credit Agreement, which replaced the Company’s prior credit agreement which was executed effective April 9, 2015 with another commercial bank, provides for a $14.0 million line of credit facility, the proceeds of which may be utilized as follows: (i) $6.0 million for working capital, letters of credit (up to $2.0 million) and general corporate purposes and (ii) $8.0 million for acquisitions. Indebtedness under the Credit Agreement is secured by the Company’s accounts receivable and inventory with advances outstanding under the working capital portion of the credit facility at any time limited to a Borrowing Base (as defined in the Credit Agreement) equal to 80% of eligible accounts receivable plus 50% of eligible inventory. Advances under the acquisition portion of the credit facility are limited to 75% of the purchase price of an acquired company and convert to a five-year term note. Borrowings bear interest at the greater of (a) zero percent or (b) the One Month ICE LIBOR plus a LIBOR Margin of 2.5%. The LIBOR Margin may increase to as high as 3.0% after September 30, 2017 depending on the Company’s cash flow leverage ratio. The interest rate as of March 31, 2017 was approximately 3.48%. The Company pays a fee of 0.25% per annum on the unused amount of the line of credit. At March 31, 2017, long-term debt consisted of the following (in thousands): Non-interest bearing, unsecured note payable assumed in acquisition (See Note 13), monthly payments of $7; maturing September 2018. $ 125 Term loan, bearing interest at 3.48%, monthly payments of $43; maturing March 2022. 2,600 Total long-term debt 2,725 Less: current portion 604 Long-term debt, net of current portion $ 2,121 The Company’s availability under its credit facilities is currently approximately $11.4 million ($6.0 million for the working capital and $5.4 million for the acquisitions). The Credit Agreement contains affirmative and negative covenants that, among other things, require the Company to maintain, beginning with the twelve-month period ending September 30, 2017, a maximum cash flow leverage ratio of no more than 3.5 to 1.0 and a minimum debt service coverage ratio of not less than 1.15 to 1.00. The maximum cash flow leverage ratio decreases to 3.25 to 1.0 on December 31, 2017 and to 3.0 to 1.0 on March 31, 2018. The Credit Agreement, which expires on March 29, 2019, also contains customary events of default which, if uncured, may terminate the Credit Agreement and require immediate repayment of all indebtedness to the lenders. Payments due on long-term debt during each of the five years subsequent to March 31, 2017 are as follows (in thousands): Twelve Months Ending March 31, 2018 $ 604 2019 561 2020 520 2021 520 2022 520 $ 2,725 The Prior Credit Agreement, which was effective through March 29, 2017, provided for a $9.0 million line of credit facility with a maturity date of April 9, 2018. No amounts related to the Prior Credit Agreement were outstanding as of March 31, 2017 other than letters of credit of approximately $0.3 million, which are in the process of being released.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	9 Months Ended
	Mar. 31, 2017
STOCK-BASED COMPENSATION [Abstract]
STOCK-BASED COMPENSATION	NOTE 7 – STOCK-BASED COMPENSATION Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant). During the three and nine months ended March 31, 2017 and 2016, stock-based compensation amounts are as follows (in thousands): Three-Months Ended March 31, Nine-Months Ended March 31, 2017 2016 2017 2016 Stock-based compensation expense included in: Cost of revenues $ 8 $ 7 $ 33 $ 25 Selling, general and administrative 108 145 356 485 Total $ 116 $ 152 $ 389 $ 510

EARNINGS PER SHARE

EARNINGS PER SHARE	9 Months Ended
	Mar. 31, 2017
EARNINGS PER SHARE [Abstract]
EARNINGS PER SHARE	NOTE 8 - EARNINGS PER SHARE Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares after considering the additional dilution related to common stock options and restricted stock. In computing diluted earnings per share, the outstanding common stock options are considered dilutive using the treasury stock method. The Company’s restricted stock awards and escrow shares that were issued in connection with the Citiwaste acquisition are treated as outstanding for earnings per share calculations since these shares have full voting rights and are entitled to participate in dividends declared on common shares, if any, and undistributed earnings. As participating securities, the shares of restricted stock are included in the calculation of basic EPS using the two-class method. For the periods presented, the amount of earnings allocated to the participating securities was not material. The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data): Three-Months Ended March 31, Nine-Months Ended March 31, 2017 2016 2017 2016 Net loss, as reported $ (668 ) $ (1,042 ) $ (1,862 ) $ (207 ) Weighted average common shares outstanding 15,994 15,462 15,930 15,449 Net loss per common share Basic and diluted $ (0.04 ) $ (0.07 ) $ (0.12 ) $ (0.01 ) Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive 269 137 304 96

EQUITY TRANSACTIONS

EQUITY TRANSACTIONS	9 Months Ended
	Mar. 31, 2017
EQUITY TRANSACTIONS [Abstract]
EQUITY TRANSACTIONS	NOTE 9 - EQUITY TRANSACTIONS During the three and nine months ended March 31, 2017 and 2016, stock options to purchase shares of the Company’s common stock were exercised as follows: Three-Months Ended March 31, Nine-Months Ended March 31, 2017 2016 2017 2016 Options Exercised 19,300 - 95,050 112,425 Proceeds (in thousands) $ 84 $ - $ 342 $ 313 Average exercise price per share $ 4.34 $ - $ 3.60 $ 2.77 As of March 31, 2017, there was $0.4 million of stock option and restricted stock compensation expense related to non-vested awards which is expected to be recognized over a weighted average period of 1.77 years. On January 7, 2013, the Company announced that its Board of Directors approved a stock repurchase program effective January 3, 2013, authorizing the Company to repurchase in the aggregate up to $3.0 million of its outstanding common stock over a two-year period. On March 5, 2015, the Board approved a two-year extension on the stock repurchase program through January 1, 2017. During the three and nine months ended March 31, 2017 and 2016, shares were repurchased as follows: Three-Months Ended March 31, Nine-Months Ended March 31, 2017 2016 2017 2016 Shares repurchased - 36,343 - 104,365 Cash paid for shares repurchased (in thousands) $ - $ 205 $ - $ 745 Average price paid per share $ - $ 5.64 $ - $ 7.14 Total shares repurchased under the program are 295,615 shares at a cost of $1.6 million. As of January 1, 2017, approximately $1.4 million remained of the Company’s $3.0 million repurchase program. The program has not been extended.

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	9 Months Ended
	Mar. 31, 2017
GOODWILL AND INTANGIBLE ASSETS [Abstract]
GOODWILL AND INTANGIBLE ASSETS	NOTE 10 – GOODWILL AND INTANGIBLE ASSETS At March 31, 2017 and June 30, 2016, intangible assets consisted of the following (in thousands): March 31, 2017 June 30, 2016 Estimated Useful Lives Original Amount Accumulated Amortization Net Amount Original Amount Accumulated Amortization Net Amount Customer relationships 7 years $ 3,007 $ (382 ) $ 2,625 $ 580 $ (60 ) $ 520 Permits 6 - 15 years 1,339 (264 ) 1,075 668 (191 ) 477 Patents 5 - 17 years 383 (261 ) 122 383 (251 ) 132 Tradename 7 years 270 (29 ) 241 - - - Non-compete 5 years 117 (18 ) 99 - - - Total intangible assets, net $ 5,116 $ (954 ) $ 4,162 $ 1,631 $ (502 ) $ 1,129 During the nine months ended March 31, 2017 and 2016, amortization expense was $0.5 million and $0.1 million, respectively. The changes in the carrying amount of goodwill since June 30, 2016 was as follows (in thousands): Balance at June 30, 2016 $ 1,039 Goodwill acquired during the nine months ended March 31, 2017 5,685 Balance at March 31, 2017 $ 6,724 As of March 31, 2017, future amortization of intangible assets is as follows (in thousands): Twelve Months Ending March 31, 2018 611 2019 611 2020 611 2021 611 2022 593 Thereafter 1,125 $ 4,162

INVENTORY

INVENTORY	9 Months Ended
	Mar. 31, 2017
INVENTORY [Abstract]
INVENTORY	NOTE 11 – INVENTORY The components of inventory are as follows (in thousands): March 31, 2017 June 30, 2016 Raw materials $ 1,458 1,388 Finished goods 3,068 2,531 Total $ 4,526 3,919

REVENUES BY SOLUTION

REVENUES BY SOLUTION	9 Months Ended
	Mar. 31, 2017
REVENUES BY SOLUTION [Abstract]
REVENUES BY SOLUTION	NOTE 12 – REVENUES BY SOLUTION The components of revenues by solution are as follows (in thousands): Three-Months Ended March 31, 2017 % Total 2016 % Total REVENUES BY SOLUTION: Mailbacks $ 4,997 58.2 % $ 4,308 64.8 % Route-based pickup services 1,641 19.1 % 628 9.4 % Unused medications 867 10.1 % 707 10.6 % Third party treatment services 149 1.7 % 70 1.1 % Other (1) 934 10.9 % 939 14.1 % Total revenues $ 8,588 100.0 % $ 6,652 100.0 % Nine-Months Ended March 31, 2017 % Total 2016 % Total REVENUES BY SOLUTION: Mailbacks $ 17,661 63.5 % $ 17,246 70.4 % Route-based pickup services 4,686 16.8 % 1,469 6.0 % Unused medications 2,400 8.6 % 2,743 11.2 % Third party treatment services 291 1.0 % 224 0.9 % Other (1) 2,788 10.1 % 2,831 11.5 % Total revenues $ 27,826 100.0 % $ 24,513 100.0 % (1) The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.

ACQUISITIONS

ACQUISITIONS	9 Months Ended
	Mar. 31, 2017
ACQUISITIONS [Abstract]
ACQUISITIONS	NOTE 13 – ACQUISITIONS Effective on July 17, 2015, the Company acquired Alpha Bio/Med Services LLC, a route-based pickup service located in Pennsylvania for total cash consideration of $0.7 million of which $0.1 million was withheld for payment of adjusted escrow amounts which settled in July 2016. The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 51 Fixed assets 70 Intangibles 267 Goodwill 413 Accounts payable and accrued liabilities (101 ) Total purchase price $ 700 Effective on December 14, 2015, the Company acquired Bio-Team Mobile LLC, a route-based pickup service located in Pennsylvania for total cash consideration of $1.0 million of which $0.1 million was withheld for payment of adjusted escrow amounts which settled in January 2017. The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 42 Fixed assets 68 Intangibles 313 Goodwill 626 Accounts payable and accrued liabilities (16 ) Total purchase price $ 1,033 Effective July 1, 2016, the Company acquired Citiwaste, LLC (“Citiwaste”), a route-based pickup service located in New York, which is in the business of medical, pharmaceutical and hazardous waste management primarily in the healthcare industry. The purchase price consists of $7.0 million in cash ($3.0 million of which was borrowed under the acquisition portion of its Credit Agreement), 413,272 shares of common stock of the Company (the “Common Stock Consideration”) valued at $1.9 million, which constitutes approximately 3.0% of the total outstanding shares of common stock of the Company, and a lease obligation to be paid to the seller for $0.1 million which is presented on the balance sheet in accrued liabilities for a total consideration of $9.0 million. The issuance of the Common Stock Consideration was not registered under the Securities Act of 1933, as amended, and was issued pursuant to an exemption from the registration requirements thereunder. The Company will hold 139,216 shares of the Common Stock Consideration in escrow for a one-year period to cover the indemnification obligations of the Sellers under the Agreement. For the three and nine months ended March 31, 2017, the Company recognized approximately $0.9 million and $2.6 million in revenues related to the operations of Citiwaste, respectively. The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Cash $ 5 Accounts receivable 495 Fixed assets 30 Intangibles 3,357 Goodwill 5,685 Accounts payable and accrued liabilities (356 ) Debt assumed (187 ) Total purchase price $ 9,029 During the three and nine months ended March 31, 2017 and 2016, the Company incurred acquisition related expenses for investment banking, legal and accounting fees which are included within selling, general and administrative expenses in the condensed consolidated statements of operations as follows (in thousands): Three-Months Ended March 31, Nine-Months Ended March 31, 2017 2016 2017 2016 Acquisition-related expenses $ - $ - $ 702 $ 151 The results of operations of the acquired business have been included in the condensed consolidated statements of operations from the date of acquisition. Pro forma results of operations for Alpha Bio/Med Services and Bio-Team Mobile are not presented because the pro forma effects, individually or in the aggregate, were not material to the Company’s consolidated results of operations. The goodwill recorded for the Alpha Bio/Med Services, Bio-Team Mobile, and Citiwaste acquisitions will be deductible for income taxes. The goodwill recognized for the acquisitions since July 1, 2015 is attributable to expected revenue synergies generated by the integration of our products and services with those acquisitions, cost synergies resulting from the consolidation or elimination of certain functions, and intangible assets that do not qualify for separate recognition such as the assembled workforce of each acquisition. Supplemental Pro Forma Data Citiwaste’s financial results have been included in our condensed consolidated financial results for the three and nine months ended March 31, 2017. The following table presents summarized unaudited pro forma financial information as if the Citiwaste acquisition occurred on July 1, 2015 (in thousands, except per-share data): Three-Months Ended March 31, Nine-Months Ended March 31, 2016 2016 Revenues $ 7,383 $ 26,705 Net loss $ (1,085 ) $ (336 ) Weighted average common shares outstanding 15,875 15,862 Net loss per common share basic and diluted $ (0.07 ) $ (0.02 )

SIGNIFICANT ACCOUNTING POLICI20

SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Mar. 31, 2017
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Revenue Recognition	Revenue Recognition The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During the three and nine months ended March 31, 2017, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $0.7 million and $2.5 million, respectively. During the three and nine months ended March 31, 2016, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $0.4 million and $2.7 million, respectively. As of March 31, 2017 and June 30, 2016, $2.6 million and $2.1 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program. Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities. Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale.
Business Combinations	Business Combinations
Income Taxes	Income Taxes
Accounts Receivable	Accounts Receivable
Stock-Based Compensation	Stock-Based Compensation
Fair Value of Financial Instruments	Fair Value of Financial Instruments
Fair Value Measurements	Fair Value Measurements · Level 1 – Quoted prices in active markets for identical assets or liabilities. · Level 2 – Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities). · Level 3 – Significant unobservable inputs (including our own assumptions in determining fair value). We use the cost, income or market valuation approaches to estimate the fair value of our assets and liabilities when insufficient market-observable data is available to support our valuation assumptions. The purchase price allocations relating to the acquisitions completed during the nine months ended March 31, 2017 and 2016 utilized level 3 inputs.

RECENTLY ISSUED ACCOUNTING ST21

RECENTLY ISSUED ACCOUNTING STANDARDS (Policies)	9 Months Ended
	Mar. 31, 2017
RECENTLY ISSUED ACCOUNTING STANDARDS [Abstract]
Recently issued accounting standards	In May 2014, guidance for revenue recognition was issued which supersedes the revenue recognition requirements currently followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. Companies have an option to use either a retrospective approach or cumulative effect adjustment approach to implement the standard. The guidance is effective for annual reporting periods beginning after December 15, 2017 (effective July 1, 2018 for the Company.) The Company is in the initial stages of evaluating the impact that the new accounting guidance will have on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company. In July 2015, guidance for inventory measurement was issued, which supersedes the policy currently followed by the Company. The new guidance requires the Company to measure inventory at the lower of cost and net realizable value. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within that reporting period. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. evaluating the impact of the new guidance on its consolidated financial statements and related disclosures. In March 2016, new guidance for stock-based compensation was issued, which simplifies the accounting for stock-based compensation related to income taxes and balance sheet and cash flow classifications. In addition, an entity can make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within the reporting period. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements.

NOTES PAYABLE AND LONG-TERM D22

NOTES PAYABLE AND LONG-TERM DEBT (Tables)	9 Months Ended
	Mar. 31, 2017
NOTES PAYABLE AND LONG-TERM DEBT [Abstract]
Schedule of long-term debt	At March 31, 2017, long-term debt consisted of the following (in thousands): Non-interest bearing, unsecured note payable assumed in acquisition (See Note 13), monthly payments of $7; maturing September 2018. $ 125 Term loan, bearing interest at 3.48%, monthly payments of $43; maturing March 2022. 2,600 Total long-term debt 2,725 Less: current portion 604 Long-term debt, net of current portion $ 2,121
Schedule of payments due on long-term debt	Payments due on long-term debt during each of the five years subsequent to March 31, 2017 are as follows (in thousands): Twelve Months Ending March 31, 2018 $ 604 2019 561 2020 520 2021 520 2022 520 $ 2,725

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Mar. 31, 2017
STOCK-BASED COMPENSATION [Abstract]
Allocated cost of stock-based compensation	During the three and nine months ended March 31, 2017 and 2016, stock-based compensation amounts are as follows (in thousands): Three-Months Ended March 31, Nine-Months Ended March 31, 2017 2016 2017 2016 Stock-based compensation expense included in: Cost of revenues $ 8 $ 7 $ 33 $ 25 Selling, general and administrative 108 145 356 485 Total $ 116 $ 152 $ 389 $ 510

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	9 Months Ended
	Mar. 31, 2017
EARNINGS PER SHARE [Abstract]
Earnings per share	The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data): Three-Months Ended March 31, Nine-Months Ended March 31, 2017 2016 2017 2016 Net loss, as reported $ (668 ) $ (1,042 ) $ (1,862 ) $ (207 ) Weighted average common shares outstanding 15,994 15,462 15,930 15,449 Net loss per common share Basic and diluted $ (0.04 ) $ (0.07 ) $ (0.12 ) $ (0.01 ) Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive 269 137 304 96

EQUITY TRANSACTIONS (Tables)

EQUITY TRANSACTIONS (Tables)	9 Months Ended
	Mar. 31, 2017
EQUITY TRANSACTIONS [Abstract]
Stock options exercised to purchase common stock	During the three and nine months ended March 31, 2017 and 2016, stock options to purchase shares of the Company’s common stock were exercised as follows: Three-Months Ended March 31, Nine-Months Ended March 31, 2017 2016 2017 2016 Options Exercised 19,300 - 95,050 112,425 Proceeds (in thousands) $ 84 $ - $ 342 $ 313 Average exercise price per share $ 4.34 $ - $ 3.60 $ 2.77
Schedule of share repurchases	During the three and nine months ended March 31, 2017 and 2016, shares were repurchased as follows: Three-Months Ended March 31, Nine-Months Ended March 31, 2017 2016 2017 2016 Shares repurchased - 36,343 - 104,365 Cash paid for shares repurchased (in thousands) $ - $ 205 $ - $ 745 Average price paid per share $ - $ 5.64 $ - $ 7.14

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	9 Months Ended
	Mar. 31, 2017
GOODWILL AND INTANGIBLE ASSETS [Abstract]
Schedule of intangible assets	At March 31, 2017 and June 30, 2016, intangible assets consisted of the following (in thousands): March 31, 2017 June 30, 2016 Estimated Useful Lives Original Amount Accumulated Amortization Net Amount Original Amount Accumulated Amortization Net Amount Customer relationships 7 years $ 3,007 $ (382 ) $ 2,625 $ 580 $ (60 ) $ 520 Permits 6 - 15 years 1,339 (264 ) 1,075 668 (191 ) 477 Patents 5 - 17 years 383 (261 ) 122 383 (251 ) 132 Tradename 7 years 270 (29 ) 241 - - - Non-compete 5 years 117 (18 ) 99 - - - Total intangible assets, net $ 5,116 $ (954 ) $ 4,162 $ 1,631 $ (502 ) $ 1,129
Schedule of goodwill	The changes in the carrying amount of goodwill since June 30, 2016 was as follows (in thousands): Balance at June 30, 2016 $ 1,039 Goodwill acquired during the nine months ended March 31, 2017 5,685 Balance at March 31, 2017 $ 6,724
Schedule of future amortization of intangible assets	As of March 31, 2017, future amortization of intangible assets is as follows (in thousands): Twelve Months Ending March 31, 2018 611 2019 611 2020 611 2021 611 2022 593 Thereafter 1,125 $ 4,162

INVENTORY (Tables)

INVENTORY (Tables)	9 Months Ended
	Mar. 31, 2017
INVENTORY [Abstract]
Components of inventory	The components of inventory are as follows (in thousands): March 31, 2017 June 30, 2016 Raw materials $ 1,458 1,388 Finished goods 3,068 2,531 Total $ 4,526 3,919

REVENUES BY SOLUTION (Tables)

REVENUES BY SOLUTION (Tables)	9 Months Ended
	Mar. 31, 2017
REVENUES BY SOLUTION [Abstract]
Schedule of billings by solution	The components of revenues by solution are as follows (in thousands): Three-Months Ended March 31, 2017 % Total 2016 % Total REVENUES BY SOLUTION: Mailbacks $ 4,997 58.2 % $ 4,308 64.8 % Route-based pickup services 1,641 19.1 % 628 9.4 % Unused medications 867 10.1 % 707 10.6 % Third party treatment services 149 1.7 % 70 1.1 % Other (1) 934 10.9 % 939 14.1 % Total revenues $ 8,588 100.0 % $ 6,652 100.0 % Nine-Months Ended March 31, 2017 % Total 2016 % Total REVENUES BY SOLUTION: Mailbacks $ 17,661 63.5 % $ 17,246 70.4 % Route-based pickup services 4,686 16.8 % 1,469 6.0 % Unused medications 2,400 8.6 % 2,743 11.2 % Third party treatment services 291 1.0 % 224 0.9 % Other (1) 2,788 10.1 % 2,831 11.5 % Total revenues $ 27,826 100.0 % $ 24,513 100.0 % (1) The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.

ACQUISITIONS (Tables)

ACQUISITIONS (Tables)	9 Months Ended
	Mar. 31, 2017
Business Acquisition [Line Items]
Summary of acquisition related costs	During the three and nine months ended March 31, 2017 and 2016, the Company incurred acquisition related expenses for investment banking, legal and accounting fees which are included within selling, general and administrative expenses in the condensed consolidated statements of operations as follows (in thousands): Three-Months Ended March 31, Nine-Months Ended March 31, 2017 2016 2017 2016 Acquisition-related expenses $ - $ - $ 702 $ 151
Summary of unaudited pro forma financial information	The following table presents summarized unaudited pro forma financial information as if the Citiwaste acquisition occurred on July 1, 2015 (in thousands, except per-share data): Three-Months Ended March 31, Nine-Months Ended March 31, 2016 2016 Revenues $ 7,383 $ 26,705 Net loss $ (1,085 ) $ (336 ) Weighted average common shares outstanding 15,875 15,862 Net loss per common share basic and diluted $ (0.07 ) $ (0.02 )
Alpha Bio Med Services LLC [Member]
Business Acquisition [Line Items]
Preliminary purchase price allocation	The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 51 Fixed assets 70 Intangibles 267 Goodwill 413 Accounts payable and accrued liabilities (101 ) Total purchase price $ 700
Bio-Team Mobile LLC [Member]
Business Acquisition [Line Items]
Preliminary purchase price allocation	The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 42 Fixed assets 68 Intangibles 313 Goodwill 626 Accounts payable and accrued liabilities (16 ) Total purchase price $ 1,033
Citiwaste LLC [Member]
Business Acquisition [Line Items]
Preliminary purchase price allocation	The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Cash $ 5 Accounts receivable 495 Fixed assets 30 Intangibles 3,357 Goodwill 5,685 Accounts payable and accrued liabilities (356 ) Debt assumed (187 ) Total purchase price $ 9,029

ORGANIZATION AND BACKGROUND (De

ORGANIZATION AND BACKGROUND (Details)	9 Months Ended
	Mar. 31, 2017StateRegion
ORGANIZATION AND BACKGROUND [Abstract]
Number of route-based pick-up service in state region	12

SIGNIFICANT ACCOUNTING POLICI31

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016	Jun. 30, 2016
Revenue Recognition [Abstract]
Revenue recorded from bill and hold inventory	$ 0.7	$ 0.4	$ 2.5	$ 2.7
Bill and hold inventory	$ 2.6		$ 2.6		$ 2.1

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
INCOME TAXES [Abstract]
Income tax expense	$ 0	$ (54)	$ 0	$ 24
Effective income tax rate reconciliation [Abstract]
Effective income tax rate				13.10%

NOTES PAYABLE AND LONG-TERM D33

NOTES PAYABLE AND LONG-TERM DEBT (Details) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017	Mar. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Jun. 30, 2016USD ($)
Long-term debt [Abstract]
Total long-term debt			$ 2,725
Less: current portion			604		$ 0
Long-term debt, net of current portion			2,121		$ 0
Unsecured Note Payable [Member]
Long-term debt [Abstract]
Monthly payments			$ 7
Maturity date			Sep. 30, 2018
Total long-term debt			$ 125
Term Loan [Member]
Line of Credit Facility [Line Items]
Maturity period			5 years
Interest rate			3.48%
Long-term debt [Abstract]
Monthly payments			$ 43
Maturity date			Mar. 31, 2022
Total long-term debt			$ 2,600
Credit Agreement [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity			$ 14,000	$ 9,000
Percentage of eligible accounts receivable considered for borrowing base			80.00%
Percentage of eligible inventory considered for borrowing base			50.00%
Maturity period			2 years
Unused capacity, commitment fee percentage			0.25%
Remaining borrowing capacity			$ 11,400
Basis spread of variable rate			0.00%
Debt cash flow of leverage ratio as on December 31, 2017	3	3.25
Long-term debt [Abstract]
Maturity date			Mar. 29, 2019
Credit Agreement [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Debt service coverage ratio			1.15
Credit Agreement [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Debt cash flow leverage ratio			3.50
Debt cash flow of leverage ratio as on December 31, 2017			3.25
Decrease in cash flow of leverage ratio as on March 31, 2018			3
Credit Agreement [Member] | Working Capital [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity			$ 6,000
Remaining borrowing capacity			6,000
Credit Agreement [Member] | Letters of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity			2,000
Credit Agreement [Member] | Acquisitions [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity			$ 8,000
Percentage of portion allocated to acquisition purchase price			75.00%
Remaining borrowing capacity			$ 5,400
Credit Agreement [Member] | LIBOR [Member]
Line of Credit Facility [Line Items]
Debt instrument, term of variable rate			1 month
Basis spread of variable rate			2.50%
Credit Agreement [Member] | LIBOR [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Basis spread of variable rate			3.00%
Prior Credit Agreement [Member]
Long-term debt [Abstract]
Maturity date			Apr. 9, 2018
Prior Credit Agreement [Member] | Letters of Credit [Member]
Line of Credit Facility [Line Items]
Amount outstanding			$ 300

NOTES PAYABLE AND LONG-TERM D34

NOTES PAYABLE AND LONG-TERM DEBT, Payments Due on Long-term Debt (Details) $ in Thousands	Mar. 31, 2017USD ($)
Payments due on long-term debt [Abstract]
2,018	$ 604
2,019	561
2,020	520
2,021	520
2,022	520
Total long-term debt	2,725
Unsecured Note Payable [Member]
Payments due on long-term debt [Abstract]
Total long-term debt	125
Term Loan [Member]
Payments due on long-term debt [Abstract]
Total long-term debt	$ 2,600

STOCK-BASED COMPENSATION (Detai

STOCK-BASED COMPENSATION (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 116	$ 152	$ 389	$ 510
Cost of Revenues [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	8	7	33	25
Selling, General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 108	$ 145	$ 356	$ 485

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016	Jun. 30, 2016
EARNINGS PER SHARE [Abstract]
Net loss, as reported	$ (668)	$ (1,042)	$ (1,862)	$ (207)	$ 13
Weighted average common shares outstanding (in shares)	15,994	15,462	15,930	15,449
Net loss per common share
Basic and diluted (in dollars per share)	$ (0.04)	$ (0.07)	$ (0.12)	$ (0.01)
Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive (in shares)	269	137	304	96

EQUITY TRANSACTIONS (Details)

EQUITY TRANSACTIONS (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Jun. 30, 2016	Jan. 07, 2013
Stock options exercised [Abstract]
Options exercised (in shares)	19,300	0	95,050	112,425
Proceeds	$ 84	$ 0	$ 342	$ 313
Average exercise price per share (in dollars per share)	$ 4.34	$ 0	$ 3.60	$ 2.77
Compensation expense related to non-vested awards	$ 400		$ 400
Weighted average period			1 year 9 months 7 days
Stock repurchase program, authorized amount							$ 3,000
Stock repurchase program, period			2 years
Stock repurchase program term extension			2 years
Shares repurchased [Abstract]
Shares repurchased (in shares)	0	36,343	0	104,365
Cash paid for shares repurchased	$ 0	$ 205	$ 0	$ 745
Average price paid per share (in dollars per share)	$ 0	$ 5.64	$ 0	$ 7.14
Total shares repurchased under the program (in shares)	295,615		295,615			295,615
Total shares repurchased under the program, at cost	$ 1,554		$ 1,554			$ 1,554
Amount remaining under repurchase program					$ 1,400

GOODWILL AND INTANGIBLE ASSET38

GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Jun. 30, 2016
Finite-Lived Intangible Assets [Line Items]
Intangible assets, original amount	$ 5,116		$ 1,631
Intangible assets, accumulated amortization	(954)		(502)
Total	4,162		1,129
Intangible assets, amortization expense	500	$ 100
Goodwill [Roll Forward]
Balance at beginning of period	1,039
Goodwill acquired during the nine months ended March 31, 2017	5,685
Balance at end of period	6,724
Future amortization of intangible assets [Abstract]
2,018	611
2,019	611
2,020	611
2,021	611
2,022	593
Thereafter	1,125
Total	$ 4,162		1,129
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	7 years
Intangible assets, original amount	$ 3,007		580
Intangible assets, accumulated amortization	(382)		(60)
Total	2,625		520
Future amortization of intangible assets [Abstract]
Total	2,625		520
Permits [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, original amount	1,339		668
Intangible assets, accumulated amortization	(264)		(191)
Total	1,075		477
Future amortization of intangible assets [Abstract]
Total	$ 1,075		477
Permits [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	6 years
Permits [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	15 years
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, original amount	$ 383		383
Intangible assets, accumulated amortization	(261)		(251)
Total	122		132
Future amortization of intangible assets [Abstract]
Total	$ 122		132
Patents [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	5 years
Patents [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	17 years
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	7 years
Intangible assets, original amount	$ 270		0
Intangible assets, accumulated amortization	(29)		0
Total	241		0
Future amortization of intangible assets [Abstract]
Total	$ 241		0
Non-compete [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	5 years
Intangible assets, original amount	$ 117		0
Intangible assets, accumulated amortization	(18)		0
Total	99		0
Future amortization of intangible assets [Abstract]
Total	$ 99		$ 0

INVENTORY (Details)

INVENTORY (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Jun. 30, 2016
Components of inventory [Abstract]
Raw materials	$ 1,458	$ 1,388
Finished goods	3,068	2,531
Total	$ 4,526	$ 3,919

REVENUES BY SOLUTION (Details)

REVENUES BY SOLUTION (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Segment Reporting Information [Line Items]
Revenue reported		$ 8,588	$ 6,652	$ 27,826	$ 24,513
Revenue percentage		100.00%	100.00%	100.00%	100.00%
Mailbacks [Member]
Segment Reporting Information [Line Items]
Revenue reported		$ 4,997	$ 4,308	$ 17,661	$ 17,246
Revenue percentage		58.20%	64.80%	63.50%	70.40%
Route-based Pickup Services [Member]
Segment Reporting Information [Line Items]
Revenue reported		$ 1,641	$ 628	$ 4,686	$ 1,469
Revenue percentage		19.10%	9.40%	16.80%	6.00%
Unused Medications [Member]
Segment Reporting Information [Line Items]
Revenue reported		$ 867	$ 707	$ 2,400	$ 2,743
Revenue percentage		10.10%	10.60%	8.60%	11.20%
Third Party Treatment Services [Member]
Segment Reporting Information [Line Items]
Revenue reported		$ 149	$ 70	$ 291	$ 224
Revenue percentage		1.70%	1.10%	1.00%	0.90%
Other [Member]
Segment Reporting Information [Line Items]
Revenue reported	[1]	$ 934	$ 939	$ 2,788	$ 2,831
Revenue percentage	[1]	10.90%	14.10%	10.10%	11.50%
[1]	The Company's other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.

ACQUISITIONS (Details)

ACQUISITIONS (Details) - USD ($) $ / shares in Units, $ in Thousands	Jul. 02, 2016	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016	Jun. 30, 2016	Dec. 14, 2015	Jul. 17, 2015
Preliminary purchase price allocation [Abstract]
Goodwill		$ 6,724		$ 6,724		$ 1,039
Business acquisition related expenses [Abstract]
Acquisition related expenses		0	$ 0	$ 702	$ 151
Alpha Bio/Med Services LLC [Member]
Preliminary purchase price allocation [Abstract]
Accounts receivable								$ 51
Fixed assets								70
Intangibles								267
Goodwill								413
Accounts payable and accrued liabilities								(101)
Total purchase price								700
Cash consideration payment of adjusted escrow and withheld for possible settlement amounts								$ 100
Bio-Team Mobile LLC [Member]
Preliminary purchase price allocation [Abstract]
Accounts receivable							$ 42
Fixed assets							68
Intangibles							313
Goodwill							626
Accounts payable and accrued liabilities							(16)
Total purchase price							1,033
Cash consideration payment of adjusted escrow and withheld for possible settlement amounts							$ 100
Citiwaste LLC [Member]
Preliminary purchase price allocation [Abstract]
Cash	$ 5
Accounts receivable	495
Fixed assets	30
Intangibles	3,357
Goodwill	5,685
Accounts payable and accrued liabilities	(356)
Debt assumed	(187)
Total purchase price	9,029
Purchase price of acquisition	$ 7,000
Number of shares for purchase price of acquisition (in shares)	413,272
Purchase price of acquisition value	$ 1,900
Percentage of total outstanding shares of common stock acquired	3.00%
Lease obligation amount	$ 100
Total consideration amount	$ 9,000
Number of shares held for common stock consideration (in shares)	139,216
Escrow period for common stock consideration				1 year
Revenues		$ 900		$ 2,600
Supplemental pro forma data [Abstract]
Revenues			7,383		26,705
Net loss			$ (1,085)		$ (336)
Weighted average common shares outstanding (in shares)			15,875,000		15,862,000
Net loss per common share basic and diluted (in dollars per share)			$ (0.07)		$ (0.02)
Citiwaste LLC [Member] | Credit Agreement [Member]
Preliminary purchase price allocation [Abstract]
Amount outstanding	$ 3,000